Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of initiating treatment with temozolomide in Glioblastoma
IRCT20150929024266N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of temozolomide in glioblastoma (GBM), sponsored by Tehran University of Medical Sciences. Started Oct 2020; status: completed.
02
Drugs
temozolomide
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on IRCT20150929024266N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150929024266N5.